The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: Approved! #quarantitties / X

The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: Approved! / X

The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: Approved! / X

The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: Approved! / X

The Boobs Approver™ - 1️⃣4️⃣3️⃣k (@Boobs_Approver) / X

The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: Approved! #quarantitties / X

The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: .@gelluhxo has been approved! / X

Estrogen Receptor

The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: Approved! #quarantitties / X

Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium